We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.73B
AUM Growth
+$371M
Cap. Flow
-$511M
Cap. Flow %
-10.8%
Top 10 Hldgs %
7.01%
Holding
1,405
New
92
Increased
215
Reduced
417
Closed
102

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$19.8M
2
CL icon
Colgate-Palmolive
CL
+$18.1M
3
FOXA icon
Fox Class A
FOXA
+$17.4M
4
WRK
WestRock Company
WRK
+$17M
5
ROL icon
Rollins
ROL
+$17M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$27.9M
2
AMGN icon
Amgen
AMGN
+$25.5M
3
PFE icon
Pfizer
PFE
+$24.6M
4
WM icon
Waste Management
WM
+$23.8M
5
SUI icon
Sun Communities
SUI
+$22.3M

Sector Composition

Rank Sector Weight
1 Financials 23.79%
2 Technology 12.1%
3 Industrials 11.16%
4 Healthcare 10.96%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
1226
DELISTED
Asensus Surgical, Inc.
ASXC
$176K ﹤0.01%
280,895
ZYXI
1227
DELISTED
Zynex
ZYXI
$175K ﹤0.01%
14,300
OBCI
1228
DELISTED
Ocean Bio-Chem Inc
OBCI
$171K ﹤0.01%
12,798
-11,777
-48% -$169K
LIVE icon
1229
Live Ventures
LIVE
$29.6M
$169K ﹤0.01%
13,702
AINC
1230
DELISTED
Ashford Inc.
AINC
$167K ﹤0.01%
19,500
-3,000
-13% -$17.7K
AAME icon
1231
Atlantic American Corp
AAME
$31.2M
$165K ﹤0.01%
79,256
SYPR icon
1232
Sypris Solutions
SYPR
$46.7M
$165K ﹤0.01%
108,404
MYO icon
1233
Myomo
MYO
$56.2M
$162K ﹤0.01%
24,000
UBX
1234
DELISTED
Unity Biotechnology
UBX
$160K ﹤0.01%
+3,045
New +$147K
PFIE
1235
DELISTED
Profire Energy, Inc
PFIE
$157K ﹤0.01%
184,700
JILL icon
1236
J. Jill
JILL
$283M
$153K ﹤0.01%
41,099
-1
-0% -$4
PZG icon
1237
Paramount Gold Nevada
PZG
$124M
$153K ﹤0.01%
131,000
ALIM
1238
DELISTED
Alimera Sciences
ALIM
$152K ﹤0.01%
35,967
+2,781
+8% +$12.5K
BWL.A
1239
DELISTED
Bowl America Incorporated
BWL.A
$151K ﹤0.01%
16,000
ARL icon
1240
American Realty Investors
ARL
$248M
$148K ﹤0.01%
13,597
NEOS
1241
DELISTED
Neos Therapeutics, Inc
NEOS
$143K ﹤0.01%
229,500
-75,000
-25% -$46.3K
STRR
1242
Star Equity Holdings
STRR
$41.7M
$141K ﹤0.01%
13,441
SVT
1243
DELISTED
Servotronics
SVT
$141K ﹤0.01%
16,653
CNDT icon
1244
Conduent
CNDT
$264M
$140K ﹤0.01%
+29,200
New +$122K
SONM icon
1245
DNA X Inc
SONM
$5.63M
$140K ﹤0.01%
108
-51
-32% -$55.7K
XPL icon
1246
Solitario Resources
XPL
$72.9M
$138K ﹤0.01%
245,000
SIF icon
1247
SIFCO Industries
SIF
$176M
$135K ﹤0.01%
16,024
LODE icon
1248
Comstock
LODE
$245M
$134K ﹤0.01%
12,900
JOB icon
1249
GEE Group
JOB
$22.5M
$133K ﹤0.01%
134,100
+56,500
+73% +$57K
TPHS
1250
DELISTED
Trinity Place Holdings Inc.com
TPHS
$132K ﹤0.01%
105,200

Similar funds

Bridgeway Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bridgeway Capital Management held 1,405 positions worth $4.73B, up 8.5% from $4.36B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Bridgeway Capital Management withdrew a net $511M in Q4 2020, closing 102 positions and reducing 417 holdings. Its most notable exit was Micron Technology, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Abbott worth $19.9M.

  • Bridgeway Capital Management's largest Q4 2020 buy was Abbott: 182,150 shares worth $19.9M.
  • Bridgeway Capital Management added most to Rollins in Q4 2020, an estimated $17M increase.
  • Bridgeway Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $24.6M.
  • Bridgeway Capital Management fully exited Micron Technology in Q4 2020, selling an estimated $27.9M.
  • Bridgeway Capital Management's ten largest holdings make up 7% of its $4.73B portfolio in Q4 2020.
  • Bridgeway Capital Management opened 92 new positions and closed 102 in Q4 2020.
  • Bridgeway Capital Management's portfolio value rose 8.5% quarter-over-quarter to $4.73B.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.